Advertisement
Research Article Free access | 10.1172/JCI114352
Howard Hughes Medical Institute, University of Michigan, Ann Arbor 48109.
Find articles by Guba, S. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Michigan, Ann Arbor 48109.
Find articles by Stella, G. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Michigan, Ann Arbor 48109.
Find articles by Turka, L. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Michigan, Ann Arbor 48109.
Find articles by June, C. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Michigan, Ann Arbor 48109.
Find articles by Thompson, C. in: JCI | PubMed | Google Scholar
Howard Hughes Medical Institute, University of Michigan, Ann Arbor 48109.
Find articles by Emerson, S. in: JCI | PubMed | Google Scholar
Published December 1, 1989 - More info
The regulation of IL-3 gene induction in human peripheral blood T cells was studied. IL-3 gene expression was inducible by crosslinking of the T cell receptor/CD3 complex using anti-CD3 MAb G19-4. Anti-CD3-induced IL-3 gene expression was found to be limited to the CD28+ T cell subset and could be augmented by costimulating T lymphocytes with antibodies directed against CD28. IL-3 expression could also be induced by costimulation of T cells with both phorbol ester and ionomycin, which are thought to mimic the intracellular effects of T cell receptor-antigen interaction. However, unlike other lymphokines such as IL-2 or granulocyte-macrophage colony-stimulating factor, IL-3 gene expression is not induced by stimulation of cells with phorbol myristate acetate and anti-CD28. We conclude that IL-3 gene regulation is under stringent control since IL-3 gene expression occurs only in the CD28+ subset of T cells, and since IL-3 induction obligately requires increased intracellular calcium.
Images.